Mono Pharmacare Limited, originally a partnership firm established in 1994, transitioned into a public limited company in October 2022. The company specializes in the marketing and distribution of a diverse range of pharmaceutical products, including antibiotics, antifungals, anti-cough and cold, antiallergics, antacids, antiemetics, analgesics, antipyretics, nutraceuticals, skincare, antiseptics, cardiac and diabetic medications, as well as cosmetics. These products are primarily sourced through contract manufacturing.
Operating with a strategic network, Mono Pharmacare deals with 168 pharmaceutical companies and maintains connections with 3,036 vendors, encompassing both retail pharmacy stores and wholesalers. The company has expanded through acquisitions, owning significant shares in partnership firms like Ahmedabad Medical Corporation and Supal Distributors LLP. With plans to issue 5.5 million equity shares through a public issue, Mono Pharmacare is poised for growth and increased market presence.
